Logan Lutton

Alkermes has initiated a phase 3 clinical program evaluating alixorexton for narcolepsy type 1 and type 2, with additional development underway for idiopathic hypersomnia.

Incyte’s phase 3 STOP-HS data show that povorcitinib improved symptoms of moderate to severe hidradenitis suppurativa in most patients over 54 weeks with a generally well-tolerated safety profile.

Sunlight can be both harmful and beneficial, meaning it’s important for dermatologists to give personalized advice to each patient, according to this morning’s 2026 American Academy of Dermatology session

Arthropods can cause or mimic a wide range of skin diseases, making accurate recognition, diagnosis and management essential in dermatologic care.

This afternoon’s session emphasized evolving vitiligo management strategies focused on emerging immune-targeted treatments, alongside a growing emphasis on holistic, patient-centered care.

At the American Academy of Dermatology 2026 meeting, dermatology leaders emphasized the growing need for advocacy to address rural access disparities and the escalating impact of climate change on patient care and health systems.

The 2026 American Academy of Dermatology meeting began today in Denver, featuring a keynote conversation this evening with John Legend on wellness, identity and his Loved01 skincare brand.

Vitiligo is a chronic autoimmune disease that affects skin pigmentation and, while not painful or contagious, requires greater attention in managed care due to its long-term nature and psychosocial impact.

A childhood teacher once told Rachel Moseley, Ph.D., there was “no point” in teaching her math. Since then, she has graduated from Cambridge University in England with a doctorate in cognitive neuroscience. She and a colleague have recently published a book of interviews exploring menopause among people with autism.

UnitedHealthcare is expanding access to doula services through eligible employer-sponsored plans, aiming to improve maternal health outcomes and provide more comprehensive pregnancy support.

In this conversation, Kirk Grisham, M.P.H., and Vishakh Unnikrishnan, M.P.H., both from the Center for HIV and Infectious Disease Policy at the O’Neill Institute, explain how federal funding cuts are destabilizing state HIV programs and why state leadership and political will now largely determine whether people keep access to HIV prevention and care.

The Department of Health and Human Services is celebrating Match Day early by providing more than $5 million in funding to Teaching Health Center Graduate Medical Education programs, supporting approximately 100 residents training in underserved and rural communities.

The FDA has approved Icotyde as the first and only IL-23R targeted oral peptide for the treatment of moderate-to-severe plaque psoriasis.

In Florida, abrupt cuts to HIV medication and insurance support are forcing patients off trusted regimens, exposing dangerous coverage gaps, and illustrating how policy decisions can quietly drive up both human and financial costs in the U.S. healthcare system.

A new research review suggests menopause may worsen obsessive-compulsive disorder symptoms for some women, with more than a quarter reporting increased severity during the transition.

The FDA has approved Cosentyx as the first interleukin-17A (IL-17A) inhibitor approved for pediatric hidradenitis suppurativa.

Women going through perimenopause who feel lonely and socially isolated are more likely to report memory and cognitive difficulties than those who report neither, with the highest risk seen in those experiencing both.

The FDA has approved Sotyktu (deucravacitinib) as the first selective TYK2 inhibitor for adults with active psoriatic arthritis.

A study published in Substance Use and Addiction found that combining nicotine replacement therapy with a rewards-based contingency management program helped people with HIV achieve higher short-term smoking cessation rates than nicotine replacement therapy alone.

Florida has reduced funding and tightened eligibility for its AIDS Drug Assistance Program, limiting access to the widely used HIV medication Biktarvy for thousands of patients, while more than 20 other states consider similar cuts amid rising program costs and stagnant federal funding.

A recent American Cancer Society study found that colorectal cancer is increasingly common, especially in adults under 50. Test your current knowledge with this slideshow and learn what you can be doing to prevent it.

UT Southwestern researchers found that testosterone may increase susceptibility to staph infections by activating bacterial communication pathways.

California health plans Blue Shield Promise and L.A. Care are partnering with the California Black Women’s Collective to help Black women in Los Angeles County gain career skills, mentorship and job opportunities through SheWorks California.

A RAND analysis finds that provisions in the One Big Beautiful Bill Act will reduce Medicaid funding to states by hundreds of billions of dollars over the next decade, driven largely by new work requirements and more frequent eligibility redeterminations that are projected to lower enrollment by millions.

Researchers highlighted the anti-inflammatory benefits of GLP-1 receptor agonists in people with HIV, plus a growing concern over rising STI rates and the cautious promise of doxycycline post-exposure prophylaxis as a partial prevention strategy.

ViiV Healthcare unveiled new data at the Conference on Retroviruses and Opportunistic Infections on next-generation long-acting HIV therapies.

An abstract presented at CROI 2026 found that continuous Medicaid coverage during the COVID-19 public health emergency was associated with decreased dependence on AIDS Drug Assistance Programs.

Zimbabwe has become one of the first countries in the world to launch a national lenacapavir program, introducing the twice-yearly injectable HIV prevention drug as part of its ongoing efforts to reduce new infections and end AIDS as a public health threat.

In this video interview, Joseph Kleiman, president of Buzz Health, says that patients should always “do their homework” to see if they are paying the lowest possible price for their prescription, whether that’s through TrumpRx or another website.